Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with leukemias and lymphomas.
Cheruku
R
R
Division of Hematology/Oncology, Scott and White Clinic, Texas A & M University College of Medicine, Temple 76508.
Uberti
J
J
Martilotti
F
F
Kaplan
J
J
D000328:Adult; D000368:Aged; D002478:Cells, Cultured; D046508:Culture Techniques / Q000379:methods; D005260:Female; D006689:Hodgkin Disease / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology / Q000502:physiology*; D015470:Leukemia, Myeloid, Acute / Q000276:immunology*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*